Trial intelligence / Profile preview

TA-CD vaccine for cocaine dependence

NCT00965263Phase 2Completed

Sponsor
New York State Psychiatric Institute
Start
Mar 2003
Primary completion
Jul 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of TA-CD in cocaine dependence, sponsored by New York State Psychiatric Institute. Started Mar 2003; status: completed.

02

Drugs

TA-CD
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT00965263.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00965263.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call